For most investors, Bandhan Bank and Ujjivan Small Finance Bank still rest in the same mental block.
Both began as leading microfinance institutions. Both traversed the financial inclusion boom into banking licences.
Both created loan books deeply focused on east and north-east India, and both suffered when that same concentration turned from a benefit to a liability.
The northeast troubles, followed by the pandemic, did not just damage collections; they shattered confidence. Gross NPAs (non-performing assets) rose, earnings became inconsistent, and investor trust took years to restore.
This December-quarter results week revived that shared history, but provided very different verdicts. Bandhan reported a ~52% YoY fall in Q3FY26 profit to ₹206 crore, even as asset quality edged forward.
Ujjivan Small Finance Bank, reporting days apart, posted a ~71% jump YoY in profit to ₹186 crore, with gross NPAs down to 2.4% and net NPAs at 0.6%. The market reacted instantly: Bandhan’s stock fell, Ujjivan’s rallied.
The departure in behaviour was not about the quarter results.
It was about what the quarter confirmed.
The market is no longer discussing where these banks came from. It is judging how each tackled damage when its model crashed, and how much unfinished business investors believe remains.
Two Banks, One Memory
Bandhan Bank and Ujjivan SFB are still grouped jointly because their stress did not arrive suddenly; it progressed over the years, in full public view.
Bandhan’s asset-quality issues did not occur overnight. Even by Q3 FY26, after multiple clean-up cycles, gross non-performing assets were still elevated at 4.7%, only modestly lower than the ~7.02% reported a year earlier. Net NPAs stood at 1.3%, signalling progress, but not closure.
A large part of this stress traced back to Assam, where sustained borrower disturbances, local disturbances, and collection disputes constantly delayed normalisation.
What made this even more harmful was not just the early shock but the stop-start nature of recovery, which drove repeated revaluations.
Ujjivan too faced similar borrower stress, but the resolution arc contrasted.
By Q3 FY26, Ujjivan had reduced GNPA to ~2.4% from ~2.7% in Q3FY25, while net NPAs were 0.6% in Q3 FY25 and Q3 FY26.
More notably, according to its latest press release on 22nd January 2026, its portfolio-at-risk (PAR) fell below ~4%, indicating that stress had not only been recognised, but aggressively reduced across the book. The provision coverage ratio rose to 76% in December 2025.
This stark contrast in stress response matters because markets don’t just price where asset quality stands.
They price how long it took the banks to get there, and how often the narrative had to be changed along the way.
How The Break Happened
The deviation between the two banks did not arise from how bad the strain became. It rose from how long ambiguity was permitted to linger.
Speed of acknowledgement
Bandhan’s asset-quality recovery has been real, but spread out. Provisioning rose gradually, expectations were amended over several quarters, and commentary remained qualified. Each step forward decreased risk, but never firmly enough to end the debate.
Ujjivan focused on resolving the issues quickly. Higher provisions were taken early in the stress cycle, and risk concentrations were cut faster.
That reduced doubt sooner, even before profits were fully normalised. Markets reward early acceptance more than perfect results.
Growth choices under stress
Bandhan’s growth posture swung between repair and retention of market share. Credit growth reduced, but not sharply enough to clearly show a behavioural reset. Deposit and loan movements remained stable, but did not adjust priorities.
Ujjivan, in contrast, made sacrifices that investors noticed. Growth was deliberately deprioritised to steady the portfolio, creating a stronger narrative arc: fix first, expand later. That clarity mattered more than growth rates.
Scale and narrative
Bandhan’s larger balance sheet and broader footprint afforded optionality but also slowed visible repair. At scale, clean break signs take longer to appear, and markets demand more proof before changing their beliefs.
Ujjivan’s smaller base implied that even smaller improvements translated into detectable ratios quickly. GNPA reduction, return on assets recovery, and the deposit momentum showed up quickly, squashing perceived risk.
Scale delayed trust for one bank.
It accelerated it for the other.
It’s not all about earnings but about how the market handles the banks’ behavioural change.
Digits That Show the Real Picture
The December-quarter results did not present new problems for either bank. They just confirmed the recovery path shareholders already believed in.
Bandhan’s trajectory has often felt incremental. Bandhan Bank’s Q3 numbers were stable on paper, but sent an inadequate signal.
Net profit excluding exceptional items dropped 52% YoY, reaching ₹206 crore. The net interest income (NIM) slipped 5.9%, showing a fall of 97 bps YoY to ~₹2,700 crore.
Gross NPAs, though elevated, fell marginally at 3.33% in Q3FY26 than 4.7% in Q3FY25. The return on assets (ROA) stayed subdued, 0.4%, falling 52 bps YoY.
These numbers underscore how recurring incomes are vulnerable to core income and the absence of one-off gains.
The stock reacted accordingly, not violently, but adversely. Bandhan Bank’s share price was ₹155 as of 30th Jan this year. The stock price slipped at a CAGR of 14% over the last three years.
Bandhan 3-Year Share Trend
The market read the quarter as continuity without closure. In terms of valuation, its current market price/book value (CMP/BV) was 1.01x lower than the industry median of 1.33x.
Ujjivan’s concentrated reset
Ujjivan Small Finance Bank, on the other hand, sent a very different signal. Net profit rose 70.8% YoY to ₹186 crore, while GNPA compressed further to 2.4% and net NPAs to 0.6%.
The return on assets (ROA) remained healthy at around 1.5%, while the deposit growth outpaced loan growth, reinforcing balance-sheet stability.
Net interest margin grew to 8.2%, with ROE around 11.5%, indicating a lucrative and advancing performance matrix.
Ujjivan SFB’s stock traded around ₹63.8 as of 30th January, growing at an annual compounded rate of 29% over the past three years, signalling a strong variation in sentiment.
Ujjivan 3-Year Share Price Trend
The stock moved up as the third-quarter numbers supported a belief already forming: that the worst corrections were behind it.
These numbers signalled a clearer closing of the pain chapter, not just incremental recovery. Its CMP/BV at 2.03x is at a premium compared to the industry median of 1.03x.
Why scale hasn’t paid off — yet
Bandhan’s long-term advantage remains scale. That has not disappeared.
A larger balance sheet offers divergence, operating leverage, and optionality once the trust is completely restored. But the sheer scale also slows noticeable repair. Improvements take longer to show up effectively, and the uncertainty declines sluggishly.
In contrast, Ujjivan’s smaller base has worked in the opposite direction. Stronger pivots became apparent in ratios quickly, reducing risk perception sooner, but that happened at the cost of a low growth ceiling and even less diversification.
In effect, Bandhan’s payoff lies after trust is fully recreated, while Ujjivan’s payoff came from how quickly they rebuilt trust. The Q3 FY26 numbers indicated that Bandhan had not crossed that line yet.
What the market is really pricing
This is not a valuation debate. It is a credibility debate.
Bandhan is not being eliminated. It is being put to the test. Investors want proof that asset quality, margins, and returns can improve together, without repeated qualifications.
Ujjivan is being compensated not for flawlessness, but for reducing doubt. The market thinks the toughest behavioural decisions have already been made.
Both stocks are trading less on optimism and more on institutional memory.
Risks, different in flavour, not magnitude
For Bandhan Bank, the scepticism is persistent. Investors may look for clear structural proof before re-rating.
Investors may continue to question its income stability, considering its sensitivity to core income, NII reduction, and slow profit momentum, especially if credit costs reemerge. Moreover, an absence of overtly strong signals may keep multiple re-rating stimuli on hold.
Ujjivan SFB’ssmaller balance sheet may restrict diversification and scale economies as growth accelerates. Higher margin sections will attract fierce competition, which could reduce returns.
Also, maintaining the deposit growth trend ahead of loans is easier in rallies. However, stress tests could mean an increase in funding costs if the market conditions tighten.
What would truly change the story?
For Bandhan, a good year’s performance will not be adequate. What the market needs is lasting ROA growth with steady asset quality, without stretching the balance sheet.
For Ujjivan, the test lies in its endurance. Can it grow substantially without re-introducing the vulnerabilities it worked to remove?
Those answers will not come from a single quarter.
A lesson the market hasn’t forgotten
This deviation was never about the December quarter, or even about earnings momentum. It was about whether the market thinks the hard part of the fix is over.
Bandhan’s recovery has unfolded as a series of improvements rather than a decisive break. Each step has decreased risk, but each has also included qualifiers. That has kept investors connected, but uncertain.
Ujjivan’s recovery followed a different arc. By concentrating pain early and righting its book visibly, it decreased the number of variables investors still needed to worry about. The result was not excitement, but acknowledgement.
That distinction now defines how the market reacts.
Bandhan must still prove closure. Ujjivan must now prove durability.
Until those tests are answered, not in quarters, but across cycles, similar numbers will continue to produce different outcomes.
The market has already moved past the crisis.
It is now pricing the quality of learning that follows it.
Disclaimer:
Note: We have relied on data from www.Screener.in throughout this article. Only in cases where the data was not available have we used an alternate, but widely used and accepted source of information.
The purpose of this article is only to share interesting charts, data points, and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educative purposes only.
Archana Chettiar is a writer with over a decade of experience in storytelling and, in particular, investor education. In a previous assignment, at Equentis Wealth Advisory, she led innovation and communication initiatives. Here she focused her writing on stocks and other investment avenues that could empower her readers to make potentially better investment decisions.
Disclosure: The writer and her dependents do not hold the stocks discussed in this article.
The website managers, its employee(s), and contributors/writers/authors of articles have or may have an outstanding buy or sell position or holding in the securities, options on securities or other related investments of issuers and/or companies discussed therein. The content of the articles and the interpretation of data are solely the personal views of the contributors/ writers/authors. Investors must make their own investment decisions based on their specific objectives, resources and only after consulting such independent advisors as may be necessary.